Patient info Search Menu

MST Continus 100 mg prolonged-release tablets – Summary of Product Characteristics (SmPC) for healthcare professionals

Medicine status: Prescription only (POM) Controlled drug (Schedule 2) Details

Medicine strength:
100 mg
Other strengths and forms:
Contains active substance:
ATC code:
Similar medicines?:

Summary of Product Characteristics (SmPC) - MST Continus 100 mg prolonged-release tablets

Sources: Original (products.mhra.gov.uk)

Facts about MST Continus 100 mg prolonged-release tablets

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Controlled drug?
Yes, Schedule 2 of the Misuse of Drugs Regulations?
  • Controlled drugs are medicines that UK law controls more strictly because they can be misused or cause dependence. The Misuse of Drugs Regulations 2001 divide them into 5 schedules: schedule 1 has the strictest rules and schedule 5 the least strict.
  • Schedule 2 is the strictest group of prescribed medicines, for example strong opioid painkillers and medicines for ADHD.
  • A prescription is valid for 28 days and usually covers up to 30 days of treatment. In England it cannot be issued as a repeat dispensing prescription.
  • When you collect it, the pharmacist must check whether you are the patient and may ask for ID.
  • Travelling abroad: carry it in your hand luggage, take your prescription or a letter from your doctor to show it is yours, and check the rules of the country you are going to with its embassy before you travel (GOV.UK).
Active substance? Morphine
Strength? 100 mg
Pharmaceutical form? Modified-release tablet
How is it taken? Oral
Pack sizes 60 tablet
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)?
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02A Opioid analgesics
        1. N02AA Natural opium alkaloid analgesics
          1. N02AA01 morphine
Marketing authorisation? PL 16950/0040
Codes? GTIN 5012854039742 · BNF 04070200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.0.0 of 2 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.